Affiliation:
1. Pan American Health Organization, Regional Office of the World Health Organization for the Americas, Washington, D.C.
Abstract
SUMMARY
Appropriate selection of donors, use of sensitive screening tests, and the application of a mandatory quality assurance system are essential to maintain the safety of the blood supply. Laws, decrees, norms, and/or regulations covering most of these aspects of blood transfusion exist in 16 of the 17 countries in Latin America that are the subject of this review. In 17 countries, there is an information system that, although still incomplete (there are no official reports on adverse events and incidents), allows us to establish progress made on the status of the blood supply since 1993. Most advances originated in increased screening coverage for infectious diseases and better quality assurance. However, in 2001 to 2002, tainted blood may have caused infections in 12 of the 17 countries; no country reached the number of donors considered adequate, i.e., 5% of the population, to avoid blood shortages, or decreased significantly the number of blood banks, although larger blood banks are more efficient and take advantage of economies of scale. In those years, paid donors still existed in four countries and replacement donors made up >75% of the blood donors in another eight countries. In addition, countries did not report the number of voluntary donors who were repeat donors, i.e., the healthiest category. In spite of progress made, more improvements are needed.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Microbiology (medical),Public Health, Environmental and Occupational Health,General Immunology and Microbiology,Epidemiology
Reference129 articles.
1. Aach, R. D., C. E. Stevens, F. B. Hollinger, J. W. Mosley, D. A. Petersen, P. E. Taylor, R. G. Johnson, L. H. Barbosa, and G. J. Nemo. 1991. Hepatitis C virus infection in post-transfusion hepatitis. An analysis with first- and second-generation assays. N. Engl. J. Med.325:1325-1329.
2. Akhavan D. 2000. Analise custo-efetividade do programa de controle da doenca de Chagas no Brasil p. 7-9. Organizacao Pan-Americana da Saude Brasilia Brazil.
3. Allain, J. P. 2003. Transfusion risks of yesterday and today. Transfusion Clin. Biol.10:1-5.
4. Alter M. 1995. Residual risk of transfusion associated hepatitis p. 23-27. In Program and Abstracts of the National Institutes of Health Development Conference on Infectious Diseases Testing for Blood Transfusion. National Institutes of Health Bethesda Md.
5. Attias A M. Lorca M. Canales R. Mercado V. Reyes and R. Child. 1984. Bol. Hosp. San Juan de Dios (Santiago) 31 : 301-306.
Cited by
148 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献